Background Information
- Maturation and assembly inhibitors (AIDSmap)
- The HIV Life Cycle (Poz)
Selected Recent Articles
- HIV maturation inhibitor BMS-955176 shows good safety and efficacy in phase 2a trial. (October 2015, AIDSmap)
- Bristol-Myers Squibb’s HIV Maturation Inhibitor Shows Promise. (October 2015, Poz)
- Five Promising HIV Drugs in the Pipeline. (September 2015, TheBodyPro)
- New Antiretrovirals, New Formulations, and New Strategies for HIV Treatment. (August 2015, Beta Blog)
- Next-generation maturation inhibitor BMS-955176 shows good antiviral activity in combination with atazanavir. (July 2015, AIDSmap)
- New maturation inhibitor BMS 176 shows potent control of HIV in small study. (July 2015, Project Inform)
- Tenofovir Alafenamide and a New Maturation Inhibitor. (March 2015, Beta Blog)
- New HIV Maturation Inhibitor Shines in Pilot Study. (February 2015, MedPage Today)
- HIV maturation inhibitor BMS-955176 looks promising in early study. (February 2015, AIDSmap)
- BMS’s Maturation Inhibitor Is Potent Against HIV in Early Trial. (February 2015, Poz)
- Myriad Genetics Suspends Its HIV Maturation Inhibitor Program. (June 2010 from Poz)
